跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,118 条关于
“HDL-C”
全部
16,118
临床试验
8,556
药物
2,173
机构
3,025
资讯
2,364
去年
High HDL Cholesterol Linked to Increased Glaucoma Risk in Older Adults, Large UK Study Finds
去年
Plozasiran Shows Promise in Reducing Triglycerides in Phase 3 and Extension Studies
去年
Obicetrapib Shows Sustained LDL-C Reduction in HeFH Patients in Phase 3 Trial
2年前
Retatrutide Shows Promise in Improving Lipid and Cardiovascular Risk Profile
去年
Obicetrapib Shows Promise in Phase 3 BROADWAY Trial, Reduces LDL-C and MACE
2年前
Obicetrapib Shows Significant LDL-C Reduction in Phase 3 Trial for Heterozygous Familial Hypercholesterolemia
去年
Merck's Enlicitide Shows Promise as First Oral PCSK9 Inhibitor in Phase 3 Trials
去年
Plozasiran Shows Promise in Reducing Triglycerides in Familial Chylomicronemia Syndrome and Severe Hypertriglyceridemia
去年
PCSK9 Inhibitors Demonstrate Efficacy and Safety in Chronic Kidney Disease Patients, Including Advanced Stages
去年
Rona Therapeutics' RN0191 Shows Promise in Phase 1 Trial for Lowering LDL-C
第 1 页,共 237 页
上一页
下一页